BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 31836551)

  • 1. Usefulness of the Bristol Stool Form Chart scoring system for the laboratory processing of faecal samples in suspected Clostridioides difficile cases.
    Corrigan RA; Sithamparanathan K; Kenny C; Wong THN
    J Hosp Infect; 2020 May; 105(1):95-97. PubMed ID: 31836551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of rectal swabs and fecal samples for the detection of
    Huletsky A; Loo VG; Longtin Y; Longtin J; Trottier S; Tremblay CL; Gilca R; Lavallée C; Brochu É; Bérubé È; Bastien M; Bernier M; Gagnon M; Frenette J; Bestman-Smith J; Deschênes L; Bergeron MG
    Microbiol Spectr; 2024 Jun; 12(6):e0022524. PubMed ID: 38687067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection.
    Lee CC; Lee JC; Chiu CW; Tsai PJ; Ko WC; Hung YP
    Microbiol Spectr; 2021 Oct; 9(2):e0079921. PubMed ID: 34668727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Bristol stool scale and its relationship to Clostridium difficile infection.
    Caroff DA; Edelstein PH; Hamilton K; Pegues DA;
    J Clin Microbiol; 2014 Sep; 52(9):3437-9. PubMed ID: 25031446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Laboratory Diagnosis of Clostridioides difficile Infection: An update of current laboratory practice.
    Somily AM; Khan MA; Morshed M
    J Infect Dev Ctries; 2021 Oct; 15(10):1364-1375. PubMed ID: 34780357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendations for the diagnosis and treatment of Clostridioides difficile infection: An official clinical practice guideline of the Spanish Society of Chemotherapy (SEQ), Spanish Society of Internal Medicine (SEMI) and the working group of Postoperative Infection of the Spanish Society of Anesthesia and Reanimation (SEDAR).
    Bouza E; Aguado JM; Alcalá L; Almirante B; Alonso-Fernández P; Borges M; Cobo J; Guardiola J; Horcajada JP; Maseda E; Mensa J; Merchante N; Muñoz P; Pérez Sáenz JL; Pujol M; Reigadas E; Salavert M; Barberán J
    Rev Esp Quimioter; 2020 Apr; 33(2):151-175. PubMed ID: 32080996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are Clostridioides difficile infections being overdiagnosed in hematopoietic stem cell transplant recipients?
    Ford CD; Lopansri BK; Coombs J; Webb BJ; Asch J; Hoda D
    Transpl Infect Dis; 2020 Aug; 22(4):e13279. PubMed ID: 32196881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of the Bristol Stool Form Chart scoring system for laboratory processing of faecal samples in suspected cases of Clostridioides difficile.
    Gauthier J
    J Hosp Infect; 2020 Aug; 105(4):778. PubMed ID: 32417432
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of Cycle Threshold, Toxin Concentration, and Clinical Characteristics of Clostridioides difficile Infection in Patients with Discordant Diagnostic Test Results.
    Shah MD; Balada-Llasat JM; Coe K; Reed E; Sandlund J; Pancholi P
    J Clin Microbiol; 2020 Apr; 58(5):. PubMed ID: 32051264
    [No Abstract]   [Full Text] [Related]  

  • 10. Does the handling time of unrefrigerated human fecal specimens impact the detection of Clostridium difficile toxins in a hospital setting?
    Modi C; DePasquale JR; Nguyen NQ; Malinowski JE; Perez G
    Indian J Gastroenterol; 2010 Jul; 29(4):157-61. PubMed ID: 20740339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Clinical and Laboratory Impact of Upgrading Clostridioides (formerly Clostridium) difficile Infection Testing from Routine to Molecular Based-Algorithm: an Observational Case-Study from the Eastern Province, Saudi Arabia.
    Alnimr A; Alwazzeh MJ; Al-Ameer A
    Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of Diarrhea, Stool Specimen Collection and Testing, and Detection of Clostridioides Difficile Infection Among Hospitalized Adults in the Muenster/Coesfeld Area, Germany.
    Effelsberg N; Buchholz M; Kampmeier S; Lücke A; Schwierzeck V; Angulo FJ; Brestrich G; Martin C; Moïsi JC; von Eiff C; Mellmann A; von Müller L
    Curr Microbiol; 2022 Dec; 80(1):37. PubMed ID: 36526801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nationwide Survey for Current Status of Laboratory Diagnosis of
    Chung HS; Park JS; Shin BM; Yoo HM; Kim H; Cho J; Lee CH; Ryoo NH; Kim JS; Chung JW; Hong KH; Kim YS; Cho YS
    J Korean Med Sci; 2022 Feb; 37(5):e38. PubMed ID: 35132844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of Clostridioides difficile Infection-Related Complications and Treatment Patterns among Nucleic Acid Amplification Test-Positive/Toxin Enzyme Immunoassay-Negative Patients.
    Miller R; Morillas JA; Brizendine KD; Fraser TG
    J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31896665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host Immune Markers Distinguish Clostridioides difficile Infection From Asymptomatic Carriage and Non-C. difficile Diarrhea.
    Kelly CP; Chen X; Williams D; Xu H; Cuddemi CA; Daugherty K; Barrett C; Miller M; Foussadier A; Lantz A; Banz A; Pollock NR
    Clin Infect Dis; 2020 Mar; 70(6):1083-1093. PubMed ID: 31211839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Easily modified factors contribute to delays in diagnosis of Clostridium difficile infection: a cohort study and intervention.
    Kundrapu S; Jury LA; Sitzlar B; Sunkesula VC; Sethi AK; Donskey CJ
    J Clin Microbiol; 2013 Jul; 51(7):2365-70. PubMed ID: 23678072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxin Enzyme Immunoassays Detect Clostridioides difficile Infection With Greater Severity and Higher Recurrence Rates.
    Guh AY; Hatfield KM; Winston LG; Martin B; Johnston H; Brousseau G; Farley MM; Wilson L; Perlmutter R; Phipps EC; Dumyati GK; Nelson D; Hatwar T; Kainer MA; Paulick AL; Karlsson M; Gerding DN; McDonald LC
    Clin Infect Dis; 2019 Oct; 69(10):1667-1674. PubMed ID: 30615074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Environmental shedding of toxigenic Clostridioides difficile by asymptomatic carriers: A prospective observational study.
    Gilboa M; Houri-Levi E; Cohen C; Tal I; Rubin C; Feld-Simon O; Brom A; Eden-Friedman Y; Segal S; Rahav G; Regev-Yochay G;
    Clin Microbiol Infect; 2020 Aug; 26(8):1052-1057. PubMed ID: 31904567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic evaluation of laboratory testing strategies for hospital-associated Clostridium difficile infection.
    Schroeder LF; Robilotti E; Peterson LR; Banaei N; Dowdy DW
    J Clin Microbiol; 2014 Feb; 52(2):489-96. PubMed ID: 24478478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic performance and accuracy of 3 molecular assays for the detection of Clostridium difficile in stool samples, compared with the Xpert® C. difficile assay.
    Azrad M; Tkhawkho L; Hamo Z; Peretz A
    J Microbiol Methods; 2020 Jan; 168():105784. PubMed ID: 31758952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.